See more : Big 5 Sporting Goods Corporation (BGFV) Income Statement Analysis – Financial Results
Complete financial analysis of Applied UV, Inc. (AUVI) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Applied UV, Inc., a leading company in the Furnishings, Fixtures & Appliances industry within the Consumer Cyclical sector.
- Dreamfolks Services Limited (DREAMFOLKS.BO) Income Statement Analysis – Financial Results
- InvestSMART Group Limited (INV.AX) Income Statement Analysis – Financial Results
- Jio Financial Services Limited (JIOFIN.BO) Income Statement Analysis – Financial Results
- Elron Ventures Ltd (ELRN.TA) Income Statement Analysis – Financial Results
- Tempur Sealy International, Inc. (TPX) Income Statement Analysis – Financial Results
Applied UV, Inc. (AUVI)
Industry: Furnishings, Fixtures & Appliances
Sector: Consumer Cyclical
Website: https://www.applieduvinc.com
About Applied UV, Inc.
Applied UV, Inc., through its subsidiaries, develops, acquires, and commercializes technology that addresses air purification and infection control in the healthcare, hospitality, commercial, municipal, and residential markets in the United States, Canada, and Europe. It operates through Disinfection and Hospitality segments. The company offers science-based solutions and products in air purification under the Airocide brand; and disinfection of hard surfaces under the Lumicide brand. It also manufactures and supplies fine decorative framed mirrors, framed arts, and bathroom vanities. The company was incorporated in 2019 and is headquartered in Mount Vernon, New York.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Revenue | 40.72M | 20.14M | 11.67M | 5.73M | 9.33M | 7.56M |
Cost of Revenue | 32.89M | 16.10M | 7.57M | 4.72M | 6.01M | 4.89M |
Gross Profit | 7.83M | 4.04M | 4.10M | 1.01M | 3.32M | 2.67M |
Gross Profit Ratio | 19.22% | 20.05% | 35.13% | 17.61% | 35.59% | 35.29% |
Research & Development | 552.22K | 319.17K | 53.41K | 310.67K | 0.00 | 0.00 |
General & Administrative | 19.71M | 13.69M | 10.54M | 4.01M | 1.92M | 1.91M |
Selling & Marketing | 661.83K | 1.11M | 799.80K | 317.56K | 0.00 | 0.00 |
SG&A | 20.37M | 14.80M | 11.34M | 4.01M | 1.92M | 1.91M |
Other Expenses | 261.84K | 274.76K | 24.87K | 10.94K | 0.00 | 2.55K |
Operating Expenses | 20.92M | 15.12M | 11.40M | 4.32M | 1.92M | 1.91M |
Cost & Expenses | 53.81M | 31.22M | 18.96M | 9.05M | 7.93M | 6.80M |
Interest Income | 0.00 | 290.34K | 0.00 | 0.00 | 15.74K | 0.00 |
Interest Expense | 1.74M | 290.34K | 0.00 | 0.00 | 15.74K | 35.64K |
Depreciation & Amortization | 4.04M | 3.48M | 1.79M | 17.64K | 8.12K | 6.25K |
EBITDA | -9.05M | -8.87M | -5.71M | -3.30M | 1.41M | 762.13K |
EBITDA Ratio | -21.59% | -37.76% | -47.17% | -57.48% | 15.13% | 10.09% |
Operating Income | -19.57M | -11.08M | -7.30M | -3.31M | 1.40M | 753.33K |
Operating Income Ratio | -48.06% | -55.04% | -62.54% | -57.79% | 15.04% | 9.97% |
Total Other Income/Expenses | 6.36M | -5.49M | -185.44K | 10.94K | 1.50M | -33.09K |
Income Before Tax | -13.20M | -16.58M | -7.48M | -3.30M | 2.91M | 720.24K |
Income Before Tax Ratio | -32.43% | -82.30% | -64.13% | -57.60% | 31.17% | 9.53% |
Income Tax Expense | 2.00M | 5.47M | -91.82K | 66.85K | 106.86K | 2.55K |
Net Income | -13.20M | -22.05M | -7.39M | -3.37M | 2.80M | 720.24K |
Net Income Ratio | -32.43% | -109.49% | -63.34% | -58.76% | 30.03% | 9.53% |
EPS | -35.63 | -216.09 | -99.62 | -73.44 | 63.75 | 17.50 |
EPS Diluted | -35.63 | -216.09 | -99.62 | -73.44 | 63.75 | 17.50 |
Weighted Avg Shares Out | 370.57K | 102.04K | 74.19K | 45.87K | 40.26K | 41.16K |
Weighted Avg Shares Out (Dil) | 370.57K | 102.04K | 74.19K | 45.87K | 40.26K | 41.16K |
Applied UV, Inc. Announces Pricing of $12.0 Million Public Offering of 10.5% Series A Cumulative Perpetual Preferred Stock
Applied UV to Present at the Ladenburg Thalmann Virtual Healthcare Conference
Applied UV Signs Distribution Agreement With FSG
Applied UV and FSG Sign Master Distributor Agreement
Applied UV Receives $850K Order For Air Purification System
Applied UV Receives Initial Purchase Orders in Excess of $850,000 from 3Sixty Biopharmaceuticals, its Exclusive Distributor for Airocide(R) Air Purification Systems for the Continent of Africa
Why Shares Of Applied UV Are Trading Higher Today
AUVI Stock Price Increases Over 7%: Why It Happened
Applied UV Announces Laboratory Results Confirm SteriLumen's Lumicide(TM) Ribbon Kills SARS-CoV-2 (COVID-19 Virus)
Applied UV: Disinfection Technology in Demand
Source: https://incomestatements.info
Category: Stock Reports